286 related articles for article (PubMed ID: 16675299)
21. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.
Ramírez-Amador V; Ponce-de-León S; Anaya-Saavedra G; Crabtree Ramírez B; Sierra-Madero J
Clin Infect Dis; 2007 Oct; 45(7):925-32. PubMed ID: 17806063
[TBL] [Abstract][Full Text] [Related]
22. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
[TBL] [Abstract][Full Text] [Related]
23. Cytomegalovirus retinitis after immune reconstitution.
Crum NF; Blade KA
AIDS Read; 2005 Apr; 15(4):186-8. PubMed ID: 15844238
[TBL] [Abstract][Full Text] [Related]
24. CMV after HAART.
Posit Aware; 1998; 9(5):18, 23. PubMed ID: 11365888
[TBL] [Abstract][Full Text] [Related]
25. Detection of opportunistic DNA viral infections by multiplex PCR among HIV infected individuals receiving care at a tertiary care hospital in South India.
Sachithanandham J; Ramamurthy M; Kannangai R; Daniel HD; Abraham OC; Rupali P; Pulimood SA; Abraham AM; Sridharan G
Indian J Med Microbiol; 2009; 27(3):210-6. PubMed ID: 19584500
[TBL] [Abstract][Full Text] [Related]
26. Gastroduodenal opportunistic infections and dyspepsia in HIV-infected patients in the era of Highly Active Antiretroviral Therapy.
Werneck-Silva AL; Prado IB
J Gastroenterol Hepatol; 2009 Jan; 24(1):135-9. PubMed ID: 19054257
[TBL] [Abstract][Full Text] [Related]
27. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era.
Madeddu G; Porqueddu EM; Cambosu F; Saba F; Fois AG; Pirina P; Mura MS
Infection; 2008 Jun; 36(3):231-6. PubMed ID: 18463787
[TBL] [Abstract][Full Text] [Related]
28. Change over time in incidence of ganciclovir resistance in patients with cytomegalovirus retinitis.
Martin BK; Ricks MO; Forman MS; Jabs DA;
Clin Infect Dis; 2007 Apr; 44(7):1001-8. PubMed ID: 17342657
[TBL] [Abstract][Full Text] [Related]
29. Initiating highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children in Europe and the United States: comparing clinical practice to guidelines and literature evidence.
Verweel G; Saavedra-Lozano J; van Rossum AM; Ramilo O; de Groot R
Pediatr Infect Dis J; 2006 Nov; 25(11):987-94. PubMed ID: 17072119
[TBL] [Abstract][Full Text] [Related]
30. Cytomegalovirus (CMV) polymerase chain reaction profiles in individuals with advanced human immunodeficiency virus infection: relationship to CMV disease.
Nokta MA; Holland F; De Gruttola V; Emery VC; Jacobson MA; Griffiths P; Pollard RB; Feinberg JE;
J Infect Dis; 2002 Jun; 185(12):1717-22. PubMed ID: 12085316
[TBL] [Abstract][Full Text] [Related]
31. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
[TBL] [Abstract][Full Text] [Related]
32. Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.
Laurichesse JJ; Persoz A; Theodorou I; Rouzioux C; Delfraissy JF; Meyer L
HIV Med; 2007 May; 8(4):213-9. PubMed ID: 17461848
[TBL] [Abstract][Full Text] [Related]
33. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
34. Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy.
Salmon-Céron D; Mazeron MC; Chaput S; Boukli N; Senechal B; Houhou N; Katlama C; Matheron S; Fillet AM; Gozlan J; Leport C; Jeantils V; Freymuth F; Costagliola D
AIDS; 2000 May; 14(8):1041-9. PubMed ID: 10853987
[TBL] [Abstract][Full Text] [Related]
35. Cytomegalovirus viremia in dried blood spots is associated with an increased risk of death in HIV-infected patients: a cohort study from rural Tanzania.
Brantsæter AB; Johannessen A; Holberg-Petersen M; Sandvik L; Naman E; Kivuyo SL; Rollag H; Bruun JN; Kvale D
Int J Infect Dis; 2012 Dec; 16(12):e879-85. PubMed ID: 23031419
[TBL] [Abstract][Full Text] [Related]
36. Opportunistic infections: an update.
Furrer H; Fux C
J HIV Ther; 2002 Feb; 7(1):2-7. PubMed ID: 11956497
[TBL] [Abstract][Full Text] [Related]
37. Aymptomatic CMV viremia is associated with increased levels of serum amyloid A in patients with advanced HIV-infection.
Steininger C; Graninger W; Zoufaly A; Zöllner B; Feucht HH; Kundi M; Stahmer I; Stellbrink HJ; van Lunzen J
Eur J Med Res; 2008 Jun; 13(6):304-8. PubMed ID: 18558558
[TBL] [Abstract][Full Text] [Related]
38. Changing pattern of primary cerebral lymphoma in the highly active antiretroviral therapy era.
Cingolani A; Fratino L; Scoppettuolo G; Antinori A
J Neurovirol; 2005; 11 Suppl 3():38-44. PubMed ID: 16540454
[TBL] [Abstract][Full Text] [Related]
39. Elucidation of cytomegalovirus disease recurrence in an HIV-1-positive patient.
Kottaridi C; Ploumidis G; Grapsas E; Feretis C; Benakis P; Filalithis P; Bouzarelou D; Nasioulas G
J Gastroenterol; 2003; 38(7):643-6. PubMed ID: 12898356
[TBL] [Abstract][Full Text] [Related]
40. Patients presenting with AIDS in the HAART era: a collaborative cohort analysis.
Mussini C; Manzardo C; Johnson M; Monforte Ad; Uberti-Foppa C; Antinori A; Gill MJ; Sighinolfi L; Borghi V; Lazzarin A; Miró JM; Sabin C;
AIDS; 2008 Nov; 22(18):2461-9. PubMed ID: 19005269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]